Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides

Int J Mol Sci. 2018 Mar 20;19(3):919. doi: 10.3390/ijms19030919.

Abstract

Various organisms exist in the oceanic environment. These marine organisms provide an abundant source of potential medicines. Many marine peptides possess anticancer properties, some of which have been evaluated for treatment of human cancer in clinical trials. Marine anticancer peptides kill cancer cells through different mechanisms, such as apoptosis, disruption of the tubulin-microtubule balance, and inhibition of angiogenesis. Traditional chemotherapeutic agents have side effects and depress immune responses. Thus, the research and development of novel anticancer peptides with low toxicity to normal human cells and mechanisms of action capable of avoiding multi-drug resistance may provide a new method for anticancer treatment. This review provides useful information on the potential of marine anticancer peptides for human therapy.

Keywords: anticancer; antiproliferative; marine organism; peptide; therapeutic agents.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents / toxicity
  • Aquatic Organisms / chemistry*
  • Biological Products / pharmacology*
  • Biological Products / therapeutic use
  • Biological Products / toxicity
  • Depsipeptides / pharmacology*
  • Depsipeptides / therapeutic use
  • Depsipeptides / toxicity

Substances

  • Antineoplastic Agents
  • Biological Products
  • Depsipeptides